Kidney tubular toxicity of maintenance pemetrexed therapy Journal Article


Authors: Glezerman, I. G.; Pietanza, M. C.; Miller, V.; Seshan, S. V.
Article Title: Kidney tubular toxicity of maintenance pemetrexed therapy
Abstract: Pemetrexed is an antifolate agent approved for the treatment of advanced lung cancer. Major side effects include myelosuppression and neutropenia. Three patients developed kidney disease while being treated with maintenance pemetrexed. Kidney biopsy specimens showed tubulointerstitial injury with tubular simplification, shrinkage, loss of brush border, and tubular atrophy in a more advanced case. Kidney function remained impaired, but stable, after discontinuation of pemetrexed therapy in all cases. Am J Kidney Dis. 58(5):817-820. (C) 2011 by the National Kidney Foundation, Inc.
Keywords: nephrotoxicity; pemetrexed; patient; cell lung-cancer; phase-i; antifolate; tubulointerstitial injury; nephrogenic diabetes-insipidus; folate homeostasis
Journal Title: American Journal of Kidney Diseases
Volume: 58
Issue: 5
ISSN: 0272-6386
Publisher: W.B. Saunders Co.  
Date Published: 2011-11-01
Start Page: 817
End Page: 820
Language: English
ACCESSION: WOS:000296385700020
DOI: 10.1053/j.ajkd.2011.04.030
PROVIDER: wos
PUBMED: 21849225
Notes: --- - Article - "Source: Wos"
Altmetric
Citation Impact
MSK Authors
  1. Maria C Pietanza
    122 Pietanza
  2. Vincent Miller
    270 Miller